Role of Fisetin in Selected Malignant Neoplasms in Women
Open Access
Abstract
A promising therapeutic window and cost-effectiveness are just two of the potential advantages of using naturally derived drugs. Fisetin (3,3′,4′,7-tetrahydroxyflavone) is a natural flavonoid of the flavonol group, commonly found in fruit and vegetables. In recent years, fisetin has gained wide attention across the scientific community because of its broad spectrum of pharmacological properties, including cytotoxic activity against most abundant cancers. By stimulating or inhibiting selected molecular targets or biochemical processes, fisetin could affect the reduction of metastasis or cancer progression, which indicates its chemotherapeutic or chemopreventive role. In this review, we have summarized the results of studies on the anticancer effects of fisetin on selected female malignancies, both in in vitro and in vivo tests, i.e., breast, cervical, and ovarian cancer, published over the past two decades. Until now, no article dedicated exclusively to the action of fisetin on female malignancies has appeared. This review also describes a growing number of nanodelivery systems designed to improve the bioavailability and solubility of this natural compound. The reported low toxicity and activity of fisetin on cancer cells indicate its valuable potential, but large-scale clinical trials are urgently needed to assess real chemotherapeutic efficacy of this flavonoid.Keywords
This publication has 80 references indexed in Scilit:
- Fisetin-loaded nanocochleates: formulation, characterisation,in vitroanticancer testing, bioavailability and biodistribution studyExpert Opinion on Drug Delivery, 2013
- Fisetin Inhibits Migration and Invasion of Human Cervical Cancer Cells by Down-Regulating Urokinase Plasminogen Activator Expression through Suppressing the p38 MAPK-Dependent NF-κB Signaling PathwayPLOS ONE, 2013
- Fisetin: A Dietary Antioxidant for Health PromotionAntioxidants & Redox Signaling, 2013
- The effects and mechanism of flavonoid–rePON1 interactions. Structure–activity relationship studyBioorganic & Medicinal Chemistry, 2013
- Dietary flavonoid fisetin targets caspase-3-deficient human breast cancer MCF-7 cells by induction of caspase-7-associated apoptosis and inhibition of autophagyInternational Journal of Oncology, 2011
- Inhibition of Human Melanoma Cell Growth by the Dietary Flavonoid Fisetin Is Associated with Disruption of Wnt/β-Catenin Signaling and Decreased Mitf LevelsJournal of Investigative Dermatology, 2011
- PIK3CA expression in invasive breast cancer: a biomarker of poor prognosisBreast Cancer Research and Treatment, 2009
- PI3K pathway activation in breast cancer is associated with the basal‐like phenotype and cancer‐specific mortalityInternational Journal of Cancer, 2009
- A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF- B-signaling pathwaysCarcinogenesis, 2008
- Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathwaysMolecular Nutrition & Food Research, 2008